Bankruptcies Leave Opioid Victims Uncompensated

Investigations show that changes to bankruptcy deals and court‑appointed trust rules for major opioid manufacturers can exclude or delay payouts to many of the people and communities harmed by the prescription‑opioid crisis. Journalists are now soliciting victims who are still waiting for money from the Purdue, Mallinckrodt and Endo settlement trusts to document who is left out and how the trusts operate. — If bankruptcy restructuring routinely sidelines hardest‑hit victims, it undermines corporate accountability, shifts costs to states and localities, and reframes how mass‑harm litigation actually compensates damage.